Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1

Cancer Research

Volumn 59, Issue 6, 1999, Pages 1315-1322

  Murphy, Brian J ^a   Andrews, Glen K ^b   Bittel, Doug ^b   Discher, Daryl J ^d   McCue, Jesica ^d   Green, Christopher J ^a   Yanovsky, Marianna ^a   Giaccia, Amato ^d   Sutherland, Robert M ^c   Laderoute, Keith R ^a   Webster, Keith A ^a  

^a SRI INTERNATIONAL   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c Varian Biosynergy Inc   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; METALLOTHIONEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HYPOXIA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SOLID TUMOR; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; BINDING, COMPETITIVE; CELL HYPOXIA; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; METALLOTHIONEIN; METALS; MICE; OXIDATION-REDUCTION; OXYGEN; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033559578     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Andrews, G. K. Regulation of metallothionein gene expression. Prog. Food Nutr. Sci., 14: 193-258, 1990.
2. Heuchel, R., Radtke, F., Georgiev, O., Stark, G., Aguet, M., and Schaffner, W. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression. EMBO J., 13: 2870-2875, 1994.
3. Dalton, T., Paria, B. C., Fernando, L. P., Huet-Hudson, Y. M., Dey, S. K., and Andrews, G. K. Activation of the chicken metallothionein promoter by metals and oxidative stress in cultured cells and transgenic mice. Comp. Biochem. Physiol., 116B: 75-86, 1997.
4. Lazo, J. S., and Pitt, B. R. Metallothioneins and cell death by anticancer drugs. Annu. Rev. Pharmacol. Toxicol., 35: 635-653, 1995.
5. Schwartz, M. A., Lazo, J. S., Yalowich, W. P., Allen, W. P., Whitmore, M., Bergonia, H. A., Tzeng, E., Billiar, T. R., Robbins, P. D., and Lancaster, J. R. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc. Natl. Acad. Sci. USA, 92: 4452-4456, 1995.
6. Studer, R., Vogt, C. P., Cavigelli, M., Hunziker, P. E., and Kagi, H. R. Metallothionein accretion in human hepatic cells is linked to cellular proliferation. Biochem. J., 328: 63-67, 1997.
7. Nagel, W. W., and Vallee, B. L. Cell cycle regulation of metallothionein in human colonic cancer cells. Proc. Natl. Acad. Sci. USA, 92: 579-583, 1995.
8. Abdel-Mageed, A., and Agrawal, K. C. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells Cancer Gene Ther., 4: 199-207, 1997.
9. Kondo, Y., Rusnak, J. M., Hoyt, D. G., Settineri, C. E., Pitt, B. R., and Lazo, J. S. Enhanced apoptosis in metallothionein null cells. Mol. Pharmacol., 52: 195-201, 1997.
10. Abdel-Mageed, A. B., and Agrawal, K. C. Activation of nuclear factor κ B: potential role in metallothionein-mediated mitogenic response. Cancer Res., 58: 2335-2338, 1998.
11. Jasani, B., and Schmid, K. W. Significance of metallothionein overexpression in human tumors. Histopathology, 31: 211-214, 1997.
12. Moussa, M., Kloth, D., Peers, G., Cherian, M. G., Frei, J. V., and Chin, J. L. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage. DNA content and serum level of prostate-specific antigen. Clin. Invest. Med., 20: 371-380, 1997.
13. Gunes, C., Heuchel, R., Georgiev, O., Muller, K. H., Lichtlen, P., Bluthmann, H., Marino, S., Aguzzi, A., and Schaffner, W. Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator MTF-i. EMBO J., 17: 2846-2854, 1998.
14. Meister, A. Glutathione deficency produced by inhibition of its synthesis and its reversal: applications in research and therapy. Cancer Res., 54: 3082-3087, 1991.
15. Skroch, P., Buchman, C., and Karin, M. Regulation of human and yeast metallothionein gene transcription by heavy metal ions. Prog. Clin. Biol. Res., 380: 113-128, 1995.
16. Samson, S. L-A., Paramchuk, W. J., Shworak, N. W., and Gedamu, L. Functional analysis of the human metallothionein-IG gene. J. Biol. Chem., 270: 25194-25199, 1995.
17. Murphy, B. J., Laderoute, K. R., Chin, R. J., and Sutherland, R. M. Metallothionein IIA is up-regulalcd by hypexia in human A431 squamous carcinoma cells. Cancer Res., 54: 5808-5810, 1994.
18. Radtke, F., Heuchel, R., Georgiev, O., Hergersberg, M., Gariglio, M., Dembic, Z., and Schaffner, W. Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J., 12: 1355-1362, 1993.
19. Brugnera, E., Georgiev, O., Radtke, F., Heuchel, R., Baker, E., Sutherland, G. R., and Schaffner, W. Cloning, chromosomal mapping and characterization of the human metal-regulatory transcription factor MTF-1. Nucleic Acids Res., 22: 3167-3173, 1994.
20. Dalton, T. P., Bittel, D., and Andrews, G. K. Reversible activation of mouse metal response clement-binding transcription factor 1 DNA binding involves zinc interaction with the zinc finger domain. Mol. Cell. Biol., 17: 2781-2789, 1997.
21. Dalton, T., Qingwen, L., Bittel, D., Liang, L., and Andrews, G. K. Oxidative stress activates metal-responsive transcription factor-1 binding activity. J. Biol Chem., 271: 26233-26241, 1996.
22. Dalton, T., Palmiter, R. D., and Andrews, G. K. Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res., 22: 5016-5023, 1994.
23. Dalton, T., Fu, K., Palmiter, R. D., and Andrews, G. K. Transgenic mice that overexpress metallothionein-I resist dietary zinc deficiency. J. Nutr., 126: 825-833, 1996.
24. Kelly, E. J., Sandgren, E. P., Brinster, R. L., and Palmiter, R. D. A pair of adjacent glucocorticoid response elements regulate expression of two mouse metallothionein genes. Proc. Natl. Acad. Sci. USA, 94: 10045-10050, 1997.
25. Vaupel, P. W., and Hockel, M. Oxygenation status of human tumors: a reappraisal using computerized pO2 histography. In: P. W. Vaupel, D. K. Kelleher, and M. Gunderoth (eds.). Funktionanalyze Biologischer Systeme. Tumor Oxygenation, pp. 219-232. Stuttgart, Jena. New York, Gustav Fischer Verlag, 1995.
26. Webster, K. A., Muscat, G. E. O., and Kedes, L. Adenovirus EIA products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature (Lond.), 332: 553-561, 1988.
27. Mazure, N. M., Chen, E. Y., Laderoute, K. R., and Giaccia, A. J. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/ Akt signaling pathway in Ha-ras-transformcd cells through a hypoxia inducible factor-1 transcriptional element. Blood, 90: 3322-3331, 1997.
28. Kondo, Y., Woo, E. S., Michalska, A. E., Choo, A., and Lazo, J. S. Metallothionein null cells have increased sensitivity to anticancer drugs. Cancer Res., 55: 2021-2023, 1995.
29. Laderoute, K. R., Grant, T. D., Murphy, B. J., and Sutherland, R. M. Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen. Int. J. Cancer. 52: 428-432, 1992.
30. Karin, M., and Richard, R. I. Human metallothionein genes: primary structure of the metallothionein-II gene and a related processed gene. Nature (Lond.), 299: 797-802, 1982.
31. Gulick, T. Transfection using DEAE-dextran. Curr. Protocols Mol. Biol., 1: 9.2.1-9.2.10, 1997.
32. Ikeda, E., Achen, M. G., Breirer, G., and Risau, W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem., 270: 19761-19766, 1995.
33. Radtke, F., Georgiev, O., Muller, H-P., Brugnera, E., and Schaffner, W. Functional domains of the heavy metal-responsive transcription regulator MTF-1. Nucleic Acids Res., 23: 2277-2286, 1995.
34. Laderoute, K. R., and Webster, K. A. Hypoxia/reoxygenation stimulates jun kinase activity through redox signaling in cardiac myocytes. Circ. Res., 80: 330-344, 1997.
35. Wu, X., Bishopric, N. H., Discher, D. J., Murphy, B. J., and Webster, K. W. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell. Biol., 16: 1035-1046, 1996.
36. Culotta, V. C., and Hamer, D. H. Fine mapping of a mouse metallothionein gene metal response element. Mol. Cell. Biol., 9: 1376-1380, 1989.
37. Stuart, G. W., Searle, P. F., and Palmiter, R. D. Identification of multiple metal regulatory elements in mouse metallothionein-I promoter by assaying synthetic sequences. Nature (Lond.), 317: 828-831, 1985.
38. Carey, M. The enhanceosome and transcriptional synergy. Cell, 92: 5-8, 1998.
39. Aniskovitch, L. P., and Jacob, S. T. Purification and characterization of a rat liver protein that recognizes CCAAT-homologous sequences of the metallothionein promoter and trans-activates this promoter. Arch. Biochem. Biophys., 341: 337-346, 1997.
40. Bittel, D., Dalton, T., Samson, S. L-A., Gedamu, L., and Andrews, G. K. The DNA-binding activity of MRE-binding transcription faclor-1 is activated in vivo and in in vitro by Zn, but not by other transition metals. J. Biol. Chem., 273: 7127-7133, 1998.
41. Palmiter, R. D. Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor. MTF-1. Proc. Natl. Acad. Sci. USA, 91: 1219-1223, 1994.
42. Muller, J. M., Krauss, B., Kaltschmidt, C., Baeuerle, P. A., and Rupec, R. A. Hypoxia induces c-fos transcription via a mitogen-activated protein kinase-dependent pathway. J. Biol. Chem., 272: 23435-23439, 1997.
43. Ausserer, W. A., Bourrat-Floeck, B., Green, C. J., and Sutherland, R. M. Regulation of c-jun expression during hypoxia and low glucose stress. Mol. Cell. Biol., 14: 5032-5042, 1994.
44. Claffey, K. P., Shih, S. C., Mullen, A., Dziennis, S., Cusick, J. L., Abrams, K. R., Lee, S. W., and Detmar, M. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell, 9: 469-481, 1998.
45. Webster, K. A., Discher, D. J., and Bishopric, N. H. Induction and nuclear accumulation of Fos and Jun proto-oncogenes in hypoxic cardiac myocytes. J. Biol. Chem., 268: 16852-16858, 1993.
46. Levy, A. P., Levy, N. S., and Goldberg, M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem., 271: 2746-2753, 1996.
47. Semenza, G. L., Nejfelt, M. K., Chi, S. M., and Antonarakis, S. E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA, 88: 5680-5684, 1991.
48. Semenza, G. L., Roth, P. H., Fang, H-M., and Wang, G. L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem., 269: 23757-23763, 1994.
49. Pugh, C. W., Tan, C. C., Jones, R. W., and Ratcliffe, P. J. Functional analysis of an oxygen-regulated transcriptional enhancer lying 3′ to the mouse erythropoietin gene. Proc. Natl. Acad. Sci. USA, 88: 10553-10557, 1991.
50. Firth, J. D., Ebert, B. L., Pugh, C. W., and Ratcliffe, P. J. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and laclate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc. Natl. Acad. Sci. USA, 91: 6496-6500, 1994.
51. Koong, A. C., Chen, E. Y., and Giaccia, A. J. Hypoxia causes the activation of NF-κB through the phosphorylation of IκB on tyrosine residues. Cancer Res., 54: 1-6, 1994.
52. Graeber, T., Koong, A. C., and Giaccia, A. J. Hypoxia induces the accumulation of p53 protein but the activation of a G1 phase checkpoint by low oxygen conditions is independent of p53 status. Mol. Cell. Biol., 14: 6264-6277, 1994.
53. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (Lond.), 379: 88-91, 1996.
54. Yao, K-S., Xanthoudakis, S., Curran, T., and O'Dwyer, P. J. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol., 14: 5997-6003, 1994.
55. Waleh, N. S., Calaoagan, J., Murphy, B. J., Knapp, A. M., Sutherland, R. M., and Laderoute, K. L. The redox-sensitive human antioxidant responsive element induces gene expression under low oxygen conditions. Carcinogenesis (Lond.), 19: 1333-1337, 1998.
56. Iyer, N. V., Kotch, L., E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, J. D., Gearhart, J. D., Lawler, A. M., and Yu, A. Y. Cellular and developmental control of oxygen homeostasis by hypoxia-inducible factor 1α. Genes Dev., 12: 149-162, 1998.
57. Sutherland, R. M., Ausserer, W. A., Murphy, B. J., and Laderoute, K. R. Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Semin. Radiat. Oncol., 6: 59-70, 1996.
58. Giaccia, A. J. Hypoxic stress proteins: survival of the fittest. Semin. Radiat. Oncol., 6: 46-58, 1996.
59. Schwartz, M. A., Lazo, J. S., Yalowich, J. C., Reylonds, I., Kagan, V. E., Tyurin, V., Kim, T-M., Watkins, S. C., and Pitt, B. R. Cytoplasmic metallothionein overexpression protects NIH3T3 cells from tert-butylhydroperxide toxicity. J. Biol. Chem., 269: 15238-15213, 1994.
60. O'Dwyer, P. J., Yao, K. S., Godwin, A. K., and Clayton, M. Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. Cancer Res., 54: 3082-3087, 1994.
61. Semenza, G. L., and Wang, G. L. A nuclear factor induced by hypoxia via de novo protein synthesis hinds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol., 12: 5447-5454, 1992.
62. Liu, Y., Cox, S. R., Motita, T., and Kourembanas, S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circ. Res., 77: 638-640, 1995.
63. Firth, J. D., Ebert, B. L., and Ratcliffe, P. J. Hypoxia regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem., 270: 21021-21027, 1995.